Clinical Trial Update: A Pharmacokinetic and Pharmacodynamic Study of DZ-002 in Patients With Advanced Solid Malignancies or Lymphoma [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic and pharmacodynamic study of DZ-002 in patients with advanced solid malignancies or lymphoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma
• Solid Tumor

Drugs mentioned

• DZ-002

Snippet

Sponsor: Da Zen Theranostics Inc | Conditions: Solid Tumor, Lymphoma | Phase 1 | Status: COMPLETED